Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Causal Attributions about Disease Onset and Relapse in Patients with Systemic Vasculitis

Peter C. Grayson, Naomi A. Amudala, Carol A. McAlear, Renée L. Leduc, Denise Shereff, Rachel Richesson, Liana Fraenkel and Peter A. Merkel
The Journal of Rheumatology May 2014, 41 (5) 923-930; DOI: https://doi.org/10.3899/jrheum.131096
Peter C. Grayson
From the US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania; University of South Florida, Tampa, Florida; School of Nursing, Duke University, Durham, North Carolina; Division of Rheumatology, Yale University, New Haven, Connecticut, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: peter.grayson{at}nih.gov
Naomi A. Amudala
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol A. McAlear
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renée L. Leduc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise Shereff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Richesson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liana Fraenkel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter A. Merkel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Abstract

Objective. Patients vary in their beliefs related to the cause of serious illness. The effect of these beliefs among patients with systemic vasculitis is not known. Our study aimed to describe causal attributions about disease onset and relapse in systemic vasculitis and to examine whether causal beliefs differ by type of vasculitis or are associated with negative health outcomes.

Methods. Patients with vasculitis were recruited to complete an online questionnaire. Categories of causal beliefs were assessed with the Revised Illness Perception Questionnaire (IPQ-R). Differences in beliefs about disease onset versus relapse were compared across different forms of vasculitis. Causal beliefs were assessed in association with several health outcomes including fatigue, functional impairments, and personal understanding of the condition.

Results. The questionnaire was completed by 692 patients representing 9 forms of vasculitis. The majority (90%) of patients had beliefs about the cause of their illness. Causal attributions were highly variable, but altered immunity and stress were the most commonly agreed-upon causal beliefs. Frequencies of causal beliefs were strikingly similar across different forms of vasculitis, with a few notable exceptions primarily in Behçet disease. Beliefs differed about causes of disease onset versus relapse. Specific beliefs about disease onset and relapse were weakly associated with fatigue, functional impairments, and understanding of the condition.

Conclusion. Patient beliefs related to the cause of systemic vasculitis are highly variable. Patterns of causal beliefs are associated with important negative health outcomes. Clinicians who care for patients with vasculitis should be mindful of these associations and consider asking about patients’ causal beliefs.

Key Indexing Terms:
  • CAUSAL ATTRIBUTIONS
  • ILLNESS PERCEPTIONS
  • VASCULITIS

The primary systemic vasculitides are a group of rare, life-threatening illnesses of unknown cause. Inflammation of blood vessels characterizes vasculitis, and preferential involvement of small, medium, or large arteries helps distinguish among the many different forms of the disease1. Although symptoms and patterns of organ system involvement can differ by type of vasculitis, all patients with vasculitis must manage both substantial burdens of disease and treatment-related side effects, either of which can significantly impair psychological well-being and quality of life2,3. Vasculitis typically manifests with an initial acute and severe event that requires high-potency immunosuppressive therapy as a life-saving or organ-preserving measure. Despite advances in medical therapy to induce disease remission, the majority of patients with vasculitis will experience 1 or more disease relapses4,5. Relapses often result in more organ damage, can be fatal, and can occur at any point in the course of disease, even after several years of sustained remission6,7.

Patient-held beliefs about the cause of their illness have been associated with emotional well-being, health behavior, quality of life, and disease understanding8,9. Although causal attributions have not been formally assessed in systemic vasculitis, evidence in other life-threatening diseases suggests that patients are more likely to seek causal explanations for illnesses that are more severe or when the disease course is both unpredictable and uncontrollable10. Causal attribution theory, as proposed by Weiner, holds that causal beliefs are meaningful because they contribute to subsequent inferences patients will make about their actions in relation to the outcome of their illness11. Therefore, causal attributions can provide important insight into an individual’s cognitive and behavioral motivation to become well and to engage in therapeutic and preventive health measures12.

The primary objective of our study was to assess causal attributions about both disease onset and relapse in patients with 9 different forms of vasculitis. An additional study objective was to determine whether patients with vasculitis discussed causal attributions with a healthcare provider and the extent to which such discussions were desirable and helpful to the patient.

MATERIALS AND METHODS

Study sample

Patients were recruited from within the Vasculitis Clinical Research Consortium (VCRC) Contact Registry to complete an online questionnaire. The VCRC Contact Registry is an online resource with international reach that can be used to conduct clinical research in vasculitis (http://rarediseasesnetwork.org/vcrc/registry). To join the registry, patients self-identify as having a particular form of vasculitis. Physician-based data were not available for diagnostic confirmation. Patients were excluded if they were < 18 years of age. An initial survey was e-mailed to members of the VCRC Contact Registry in November 2011. Two separate reminder e-mails were sent 3 weeks apart, and study recruitment closed in January 2012. Ethics approval was provided by the University of South Florida Institutional Review Board.

Demographic information including age, sex, race, ethnicity, highest education level, and annual income was recorded. Disease characteristics were assessed per self-report and included disease status (active versus remission), disease duration (continuous variable), disease severity (defined categorically as history of at least 1 predefined organ or life-threatening symptom), and history of relapse.

Causal attributions assessment

All study patients were asked whether they had beliefs about what caused their vasculitis and whether they had discussed these beliefs with a healthcare provider. Respondents who discussed their beliefs with a healthcare provider were asked whether this discussion was helpful and whether the provider was respectful of their beliefs. Respondents who had not discussed their beliefs with a healthcare provider were asked whether discussion of beliefs would be helpful, if they would like to discuss their beliefs, and if they felt embarrassed to discuss these beliefs. Responses to these questions were coded as “yes” or “no”.

The revised version of the Illness Perception Questionnaire (IPQ-R) was used to assess categories of causal attributions13. The IPQ-R was developed in accordance with the common sense model of illness perceptions, which asserts that patients consistently structure illness perceptions into common dimensions14. Nine dimensions of cognitive representations or beliefs about any illness, including a section on causal attributions, are assessed within the IPQ-R. The IPQ-R has been determined to have good internal reliability, discrimination, and predictive validity13. Patients were instructed to provide “your own views about the factors that caused your illness rather than what others including doctors and family members may have suggested to you.” Patients were then asked to indicate level of agreement to 18 specified categories of causal beliefs on a scale of 1: strongly disagree; 2: disagree; 3: neither agree nor disagree; 4: agree; and 5: strongly agree.

The IPQ-R has been used in numerous patient populations and can be modified for a particular disease interest13. Given the frequent relapsing nature of vasculitis, the IPQ-R was modified for our study to assess causal beliefs about both disease onset and relapse. The same 18 causal belief items were assessed for disease onset and relapse, and an additional 3 belief items (“stopped taking my medications”, “change in my medications”, and “change in the weather”) were only assessed for relapse. The additional belief items were chosen because patients with other rheumatic diseases frequently report these beliefs as causal for disease relapse9. Only patients who reported a history of at least 1 disease relapse were queried about beliefs related to relapse.

Outcome assessment

Fatigue is highly prevalent in vasculitis15,16 and is rated by patients to be one of the most important burdens of disease17. The Multidimensional Fatigue Inventory (MFI-20) was used to quantify fatigue18. The MFI-20 has been used in a variety of diseases to assess 5 domains of fatigue. The “general fatigue” domain has been shown to best differentiate patients with vasculitis from healthy controls19. The “general fatigue” domain of the MFI-20 consists of 4 questions scored on a 5-point Likert scale. Higher scores on the MFI-20 indicate a greater degree of perceived fatigue.

Functional impairment

Three subscales of the Medical Outcomes Study General Health Survey (MOS) were used to measure functioning20. “Physical” functioning, defined by activities such as climbing stairs and walking 1 block, was assessed by responses to 6 items, each rated on a 3-point scale (“limited for more than 3 months”, “limited for 3 months or less”, “not limited at all”). “Role” functioning, defined by the ability to perform schoolwork, housework, or job-related tasks, was assessed by responses to 2 items, each rated on a 3-point scale (“limited for more than 3 months” to “not limited at all”). “Social” functioning was assessed by 1 item, which queried how often over the last month vasculitis has limited social activities (such as visiting with friends or close relatives), with responses recorded on a 6-point scale (ranging from “none of the time” to “all of the time”). Higher scores on the MOS subscales indicate worse levels of functioning.

Illness coherence

The “illness coherence” domain within the IPQ-R was used to assess each participant’s perceived understanding of their condition13. Illness coherence was assessed by 5 items scored on a 5-point scale corresponding to level of agreement (ranging from 1: strongly disagree, to 5: strongly agree) in response to statements such as “my vasculitis doesn’t make any sense to me” and “I have a clear picture or understanding of my vasculitis”. Higher scores on the illness coherence domain represent increased perceived understanding of vasculitis.

Statistical analyses

Mean scores for each causal belief item on the IPQ-R were calculated for attributions related to disease onset and relapse. The percentage of respondents who indicated agreement (either “agree” or “strongly agree”) to a particular belief item was calculated. Mean scores of each belief item assessed for disease onset and relapse were compared using paired t tests with a Bonferroni correction applied to adjust for multiple comparisons21. Because 18 items were compared, a p value < 0.003 was used to define the threshold for statistical significance in these comparisons. As recommended by the designers of the IPQ-R, factor analysis was performed to potentially reduce the number of causal belief items13,22. Principal components analysis with a varimax rotation was performed, and subsequent factor loadings for the individual items and their factors were described. Factor loading patterns for causal attributions related to disease onset and relapse were examined separately. Internal reliability for each factor was calculated using Cronbach’s alpha coefficient. Differences in mean IPQ-R scores for individual causal belief items or factors were compared between different types of vasculitis using 1-way ANOVA with posthoc Scheffe tests. Only those types of vasculitis in which at least 30 patients completed the survey were included in these comparative analyses, and a p value of < 0.05 defined statistical significance. For any identified differences in beliefs by type of vasculitis, adjustments for potential demographic and clinical confounders were performed using linear regression models. Correlations between causal belief items or factors and MFI-20 scores, MOS functional scores (physical, social, and role), and scores on the illness coherence domain of the IPQ-R were assessed using Pearson’s correlation coefficient. A Bonferroni correction was applied to account for multiple outcome comparisons. Because 5 outcomes were evaluated, a p value < 0.01 was used to define statistical significance for these analyses.

RESULTS

Patient characteristics

Subject characteristics are displayed in Table 1. The survey was completed by 692 patients with 9 different types of vasculitis. Various types of small vessel vasculitis were represented [granulomatosis with polyangiitis (GPA), microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss), IgA vasculitis (Henoch-Schonlein purpura)]. The medium vessel vasculitis that was represented was polyarteritis nodosa. Of the large vessel vasculitis types, the survey included giant cell arteritis and Takayasu arteritis. Other types of vasculitis with no clear predilection for a specific vessel size were also represented, including central nervous system vasculitis (CNS vasculitis) and Behçet disease.

View this table:
  • View inline
  • View popup
Table 1.

Participant characteristics.

The majority of patients reported a diagnosis of GPA, and > 30 patients were recruited for each type of vasculitis, except CNS vasculitis and IgA vasculitis. The majority of patients were female (70%), white (89%), born in the United States (68%), college graduates (66%), and > 50 years of age. Most patients reported several years of disease duration at the time of study participation. Active disease was reported by 55% of patients, and a history of at least 1 severe disease manifestation was reported by 46% of patients. Most study patients (72%) reported at least 1 disease relapse.

Discussion of causal beliefs with healthcare provider

Of 692 study patients, 90% had beliefs about what caused their vasculitis. Sixty percent of those patients had discussed causal attributions with a healthcare provider. Of those who had discussed their beliefs, 59% found the discussion to be helpful and 75% felt that the healthcare provider was respectful of their beliefs. Of the 30% of patients who had causal beliefs but had not discussed their beliefs with a healthcare provider, 49% wanted to discuss their beliefs, 41% believed such a discussion would be helpful, and 16% felt embarrassed to discuss their beliefs. Patients who had discussions with their healthcare provider about causal beliefs had significantly higher mean scores on the illness coherence domain of the IPQ-R than those who had not discussed their beliefs (3.5 vs 3.2; p < 0.01), indicating a better perceived understanding of their condition.

Categories of causal beliefs

The distribution of responses for each causal belief item is displayed in Table 2. “Altered immunity” and “stress or worry” were the most commonly agreed-upon causal attributions for both disease onset and relapse, with the majority of respondents endorsing these beliefs. A “change in my medications” was frequently considered a cause of relapse. Responses to 9 out of 18 items significantly differed between causal beliefs related to disease onset and relapse. “Chance or bad luck” and “pollution in environment” were more strongly held causes of disease onset. “Diet or eating habits,” “poor medical care,” “my own behavior,” “my mental attitude,” “family problems,” “overwork,” and “my emotional state” were more strongly held causes of relapse. Patients who had conversations about causal beliefs with their healthcare provider were significantly less likely to attribute disease onset and relapse to chance compared to patients who had never discussed their beliefs (p < 0.01), but the frequencies of other causal attributions were similar.

View this table:
  • View inline
  • View popup
Table 2.

Categories of causal attributions in systemic vasculitis.

Factor analysis of causal belief items

Factor analysis suggested a 5-factor loading of belief items for both disease onset and relapse. Two factors contained the same items for both disease onset and relapse. A psychological factor contained the items “stress or worry,” “my mental attitude,” “family problems,” “overwork,” “my emotional state,” and “my personality.” All items loaded > 0.50 on the factor pattern matrix, and the Cronbach’s alpha coefficient for this factor was 0.86 (disease onset) and 0.87 (relapse). A medical risk factor contained the items “diet or eating habits,” “ageing,” “alcohol,” “smoking,” and “accident or injury.” All items loaded > 0.50 on the factor pattern matrix, and the Cronbach’s alpha coefficient for this factor was 0.81 (disease onset) and 0.79 (relapse). A medication factor contained the items “change in my medications” and “stopped taking my medications.” This factor was only assessed in relation to relapse, both items loaded with > 0.50 on the factor pattern matrix, and the resultant Cronbach’s alpha coefficient was 0.65. No further reduction in items was suggested by the factor analyses, so all other beliefs were analyzed as individual items.

Causal attributions by type of vasculitis

The mean IPQ-R scores for causal belief items or factors are reported by type of vasculitis in Table 3. Causal attributions for disease-onset and relapse are displayed for those types of vasculitis with n > 30 patients. There were few differences in causal attributions by type of vasculitis. Attributing alterations in immunity as a cause of disease onset and relapse was the most strongly endorsed belief across all types of vasculitis. More patients with Behçet disease attributed disease onset and relapse to infectious and hereditary causes compared to patients with some other types of vasculitis, and these differences remained significant after adjustments for clinical and demographic characteristics. A change in weather and medications was also more strongly endorsed in Behçet disease as a cause of relapse; however, these differences did not persist after adjustment for age of the participant. Younger age was associated with ascribing relapse to medication factors (r = 0.21, p < 0.001) and to changes in weather (r = 0.14, < 0.001).

View this table:
  • View inline
  • View popup
Table 3.

Causal attributions by vasculitis type.

Correlation between causal attributions and outcomes

There were several significant, weak associations between causal belief items or factors and fatigue, function, and illness coherence (Table 4). Causal beliefs related to medical risk factors and chance or bad luck were consistently and significantly associated with lower illness coherence scores for disease onset and relapse attributions. Attributing disease onset to pollution in the environment was associated with impaired physical and social functioning. Attributing relapse to psychological and medication factors was associated with a higher level of reported fatigue and impairments in physical, role, and social functioning.

View this table:
  • View inline
  • View popup
Table 4.

Correlations between causal attributions, fatigue, functional impairment, and illness coherence.

DISCUSSION

The vast majority (90%) of patients with vasculitis have beliefs about the cause of their illness. Most of those patients have discussed their beliefs with a healthcare provider and found these discussions to be helpful. About one-third of patients with vasculitis have never discussed causal attributions with a healthcare provider and a substantial number of these patients would like to have these conversations but may feel embarrassed to broach the topic. Specific causal attributions were highly variable among individuals with vasculitis, but the general frequencies of categorical beliefs were strikingly similar across the different vasculitides. In cases where there were differences in causal belief by type of vasculitis, age was often a confounder. Younger age, a common risk factor for medication noncompliance23, was strongly associated with beliefs that medication factors, including alterations in medication regimen and medication noncompliance, were causal for relapse in vasculitis. Categories of causal attributions were weakly associated with deleterious outcomes including fatigue, functional impairments, and perceived lack of understanding of the condition.

Scientific understanding about the etiology of vasculitis is limited; however, an interaction between genetic and environmental factors leading to the development of autoimmunity likely underpins disease24. Accordingly, most patients with vasculitis acknowledged autoimmune factors as causal in the disease process. Of all types of vasculitis under study, the strongest scientific evidence for a hereditary component of disease has been reported in Behçet disease25,26,27, and hereditary factors among patients with Behçet disease were indeed more commonly attributed as causal than in other forms of vasculitis. Few environmental exposures have been associated with vasculitis. Silica dust exposure has been associated with development of GPA and EGPA28,29, which are 2 types of vasculitis with prominent airway involvement. Although not statistically significant, the highest disease onset causal attribution scores for environmental exposure were seen in patients with GPA and EGPA. Infectious causes have long been sought in vasculitis; however, apart from the role of viral hepatitis in a subset of patients with polyarteritis nodosa, no causal infectious agents have been identified for any type of vasculitis included in this study. There is no scientific evidence linking psychological factors or variations in weather patterns with disease onset or relapse in vasculitis, yet these causal beliefs were commonly held and significantly associated with negative outcomes such as fatigue and functional impairment.

Causal attribution theory posits that the structure of thinking, rather than the causal beliefs themselves, is more relevant for predicting behavioral motivation and emotional response to illness11. Perceived causes of success and failure share 3 common dimensions: locus of causality, stability, and controllability12. Locus of causality refers to whether the source of the belief is internal (e.g., stress or feeling tired) or external (e.g., pollution in the environment or bad luck). Stability indicates the changeable aspects of the belief over time, and controllability differentiates whether an individual has volitional ability to modify the source of a belief. When viewed from the perspective of causal dimensions, some interesting findings in this study emerge. A shift in locus of causality was observed for beliefs about disease onset versus relapse. Patients with vasculitis more strongly ascribed causal beliefs about disease onset to external factors (pollution in the environment, chance, or bad luck), yet causal beliefs about relapse were predominantly attributed to internal factors (diet or eating habits, my own behavior, my mental attitude, family problems, overwork, my emotional state). Additionally, patients who endorsed external over internal causal beliefs were more likely to report a poorer understanding of their condition.

When dimensions of causal attributions are considered in combination, as encouraged by causal attribution theory, predictable cognitive illness representations and behavioral consequences are further apparent11. For example, external, stable, and uncontrollable attributions preserve self-esteem but decrease expectations that behavioral modification can affect the course of illness and that future recovery is possible. Internal, unstable, and controllable attributions decrease self-esteem, but they also increase expectations for coping strategies and bolster feelings that behavioral modification can improve outcomes. Beliefs that a change in weather was causal for relapse (an external, unstable, and uncontrollable attribution) were most strongly and consistently associated with negative outcomes including higher levels of fatigue and impairment in physical, social, and role functioning. Beliefs that pollution in the environment (an external, stable, and uncontrollable attribution) was causal for disease onset were associated with impairments in physical and social functioning. Psychological factors (which tend to be internal, unstable, and controllable attributions) were also associated with worse fatigue and impairments in role and social functioning. According to the principles of attribution theory, out of all of the identified beliefs associated with negative outcomes in this study, psychological factors are most likely to motivate an individual’s adaptive response to overturn or actively address the adverse outcome and could be a focus for behavioral intervention.

The categories of causal attributions commonly reported by patients with vasculitis are not unique and mirror descriptions of causal attributions in other rheumatic diseases. Patients with rheumatoid arthritis (RA)9 and systemic lupus erythematosus30 most frequently attribute disease onset to hereditary factors, autoimmune factors, and psychological stressors. Similarly, patients with RA commonly attribute relapse to psychological stressors and changes in weather, and categorical causal beliefs have also been modestly associated with a series of negative outcomes in RA including functional impairments, greater disease activity, poorer psychosocial adjustment, and illness unpredictability9. Conversely, causal attributions in vasculitis differ markedly from the structure of beliefs in patients afflicted by diseases with known strong causal associations, such as chronic obstructive pulmonary disease and lung cancer31,32.

The results in our study have important implications for healthcare providers caring for patients with systemic vasculitis. According to the self-regulation model of illness proposed by Leventhal, et al14, patients with vasculitis actively process information about their condition, evaluate attempts to moderate or cope with the effects of illness, and form representations of illness, including causal beliefs, based on their experiences. The majority of patients with vasculitis hold beliefs about the cause of their illness, are interested in discussing these beliefs with a healthcare provider, and generally find these discussions helpful. The findings in this report provide context for healthcare providers to engage in discussions about causal attributions with their patients. These discussions provide an opportunity to educate patients about causal beliefs commonly held by patients with vasculitis in relation to known scientific evidence about the etiology of these diseases. A patient’s specific causal attributions may also provide useful clinical information. For example, beliefs about the role of psychological stressors may prompt further inquiry into a patient’s perceived negative consequences of illness, understanding of disease, and behavioral motivation and may help to identify patients who could benefit from behavioral interventions such as stress management programs. Beliefs that medication factors cause relapse, particularly in younger patients, may prompt further inquiry into medication compliance. A belief that chance or bad luck is causal for disease onset may prompt further discussion about that individual’s perceived understanding of the condition.

Our study has some potential limitations to consider. Correlations between specific causal attributions and health outcomes, while statistically significant, demonstrated only weak association (r = 0.12–0.19). Despite the low magnitude of correlation between specific causal beliefs and health outcomes, broader dimensions of causal attributions were consistently associated with negative health outcomes in accordance with the principles of causal attribution theory. Recruitment of patients online and the use of quantitative rather than qualitative methods to assess causal beliefs may limit the generalizability of the findings and restrict the potential types of causal beliefs identified. However, the frequencies of specific categorical beliefs and the patterns of association with health outcomes mirrored findings in other chronic rheumatic diseases, lessening concerns about selection bias and ascertainment bias. The cross-sectional nature of this study is another important limitation that precludes study of whether causal attributions predictably change over the disease course. The strengths of our study include a large cohort of a rare disease with a broad representation of many rare disease subtypes. Further, this is the first study of its kind to assess causal attributions about disease onset and relapse in systemic vasculitis, and the findings could be used to facilitate clinician-patient discussions about causal attributions in these diseases.

The majority of patients with vasculitis have beliefs about disease onset and relapse. These beliefs are highly variable and may provide important clinical information and opportunities for discussion that could strengthen therapeutic alliance. Similar to other chronic, relapsing, and life-threatening diseases, causal attributions in vasculitis are associated with important negative health outcomes and may predict health-related behaviors. Clinicians who care for patients with vasculitis should be mindful of these associations and consider asking about patients’ causal beliefs.

Footnotes

  • Sponsored by the Vasculitis Clinical Research Consortium, which has received support from NIAMS (U54AR057319), the National Center for Research Resources (U54 RR019497); the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. Dr. Grayson receives support from an American College of Rheumatology-Rheumatology Research Foundation Scientist Development Award. Dr. Fraenkel receives support from NIAMS (K24 AR060231-01).

  • Accepted for publication January 7, 2014.

REFERENCES

  1. 1.↵
    1. Jennette JC,
    2. Falk RJ,
    3. Bacon PA,
    4. Basu N,
    5. Cid MC,
    6. Ferrario F,
    7. et al.
    2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1–11.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Koutantji M,
    2. Pearce S,
    3. Harrold E
    . Psychological aspects of vasculitis. Rheumatology 2000;39:1173–9.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Koutantji M,
    2. Harrold E,
    3. Lane SE,
    4. Pearce S,
    5. Watts RA,
    6. Scott DG
    . Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 2003;49:826–37.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Gordon M,
    2. Luqmani RA,
    3. Adu D,
    4. Greaves I,
    5. Richards N,
    6. Michael J,
    7. et al.
    Relapses in patients with a systemic vasculitis. Q J Med 1993;86:779–89.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Reinhold-Keller E,
    2. Beuge N,
    3. Latza U,
    4. de Groot K,
    5. Rudert H,
    6. Nolle B,
    7. et al.
    An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000;43:1021–32.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Walsh M,
    2. Flossmann O,
    3. Berden A,
    4. Westman K,
    5. Hoglund P,
    6. Stegeman C,
    7. et al.
    Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2012;64:542–8.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Seo P,
    2. Min YI,
    3. Holbrook JT,
    4. Hoffman GS,
    5. Merkel PA,
    6. Spiera R,
    7. et al.
    Damage caused by Wegener’s granulomatosis and its treatment: prospective data from the Wegener’s Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 2005;52:2168–78.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Petrie KJ,
    2. Jago LA,
    3. Devcich DA
    . The role of illness perceptions in patients with medical conditions. Curr Opin Psychiatry 2007;20:163–7.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Affleck G,
    2. Pfeiffer C,
    3. Tennen H,
    4. Fifield J
    . Attributional processes in rheumatoid arthritis patients. Arthritis Rheum 1987;30:927–31.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Affleck G,
    2. Tennen H,
    3. Croog S,
    4. Levine S
    . Causal attribution, perceived benefits, and morbidity after a heart attack: an 8-year study. J Consult Clin Psychol 1987;55:29–35.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Weiner B
    . An attributional theory of achievement motivation and emotion. Psychol Rev 1985;92:548–73.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Roesch SC,
    2. Weiner B
    . A meta-analytic review of coping with illness: do causal attributions matter? J Psychosom Res 2001;50:205–19.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Moss-Morris R,
    2. Weinman J,
    3. Petrie KJ,
    4. Horne R,
    5. Cameron LD,
    6. Buick D
    . The revised Illness Perception Questionnaire (IPQ-R). Psychology Health 2002;17:1–16.
    OpenUrlCrossRef
  14. 14.↵
    1. Leventhal H,
    2. Benyamini Y,
    3. Brownlee S,
    4. Diefenbach M,
    5. Leventhal EA,
    6. Patrick-Miller L,
    7. et al.
    Illness representations: theoretical foundations. In: Petrie KJ, Weinman J, eds. Perceptions of health and illness. Amsterdam: Harwood Academic Press; 1997.
  15. 15.↵
    1. Basu N,
    2. Jones GT,
    3. Fluck N,
    4. MacDonald AG,
    5. Pang D,
    6. Dospinescu P,
    7. et al.
    Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology 2010;49:1383–90.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Hajj-Ali R
    . Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res 2011;63:827–33.
    OpenUrlCrossRef
  17. 17.↵
    1. Herlyn K,
    2. Hellmich B,
    3. Seo P,
    4. Merkel PA
    . Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res 2010;62:1639–45.
    OpenUrlCrossRef
  18. 18.↵
    1. Smets EM,
    2. Garssen B,
    3. Bonke B,
    4. De Haes JC
    . The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315–25.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Buhl BM,
    2. Rutgers A,
    3. Sanders JS,
    4. Kallenberg C,
    5. Stegeman C
    . Dimensions of fatigue in ANCA-AAV: level of physical activity is associated with less fatigue, but not to age of disease onset or duration. 15th International Vasculitis and ANCA Workshop. [Internet. Accessed February 19, 2014.] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04338.x/pdf
  20. 20.↵
    1. Stewart AL,
    2. Hays RD,
    3. Ware JE Jr.
    The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724–35.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Bland JM,
    2. Altman DG
    . Multiple significance tests: the Bonferroni method. BMJ 1995;310:170.
    OpenUrlFREE Full Text
  22. 22.↵
    1. Weinman J,
    2. Petrie KJ,
    3. Sharpe N,
    4. Walker S
    . Causal attributions in patients and spouses following first-time myocardial infarction and subsequent lifestyle changes. Br J Health Psychol 2000;5:263–73.
    OpenUrlCrossRef
  23. 23.↵
    1. Jin J,
    2. Sklar GE,
    3. Min Sen Oh V,
    4. Chuen Li S
    . Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag 2008;4:269–86.
    OpenUrlPubMed
  24. 24.↵
    1. Savage CO,
    2. Harper L,
    3. Adu D
    . Primary systemic vasculitis. Lancet 1997;349:553–8.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Verity DH,
    2. Marr JE,
    3. Ohno S,
    4. Wallace GR,
    5. Stanford MR
    . Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999;54:213–20.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Gul A,
    2. Inanc M,
    3. Ocal L,
    4. Aral O,
    5. Konice M
    . Familial aggregation of Behcet’s disease in Turkey. Ann Rheum Dis 2000;59:622–5.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Molinari N,
    2. Kone Paut I,
    3. Manna R,
    4. Demaille J,
    5. Daures JP,
    6. Touitou I
    . Identification of an autosomal recessive mode of inheritance in paediatric Behcet’s families by segregation analysis. Am J Med Genet A 2003;122A:115–8.
    OpenUrl
  28. 28.↵
    1. Hogan SL,
    2. Satterly KK,
    3. Dooley MA,
    4. Nachman PH,
    5. Jennette JC,
    6. Falk RJ
    . Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 2001;12:134–42.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Mahr AD,
    2. Neogi T,
    3. Merkel PA
    . Epidemiology of Wegener’s granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol 2006;24:S82–91.
    OpenUrlPubMed
  30. 30.↵
    1. Taieb O,
    2. Bricou O,
    3. Baubet T,
    4. Gaboulaud V,
    5. Gal B,
    6. Mouthon L,
    7. et al.
    Patients’ beliefs about the causes of systemic lupus erythematosus. Rheumatology 2010;49:592–9.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Hoth KF,
    2. Wamboldt FS,
    3. Bowler R,
    4. Make B,
    5. Holm KE
    . Attributions about cause of illness in chronic obstructive pulmonary disease. J Psychosom Res 2011;70:465–72.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Lehto RH
    . Causal attributions in individuals with suspected lung cancer: relationships to illness coherence and emotional responses. J Am Psychiatr Nurses Assoc 2007;13:109–15.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 5
1 May 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Causal Attributions about Disease Onset and Relapse in Patients with Systemic Vasculitis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Causal Attributions about Disease Onset and Relapse in Patients with Systemic Vasculitis
Peter C. Grayson, Naomi A. Amudala, Carol A. McAlear, Renée L. Leduc, Denise Shereff, Rachel Richesson, Liana Fraenkel, Peter A. Merkel
The Journal of Rheumatology May 2014, 41 (5) 923-930; DOI: 10.3899/jrheum.131096

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Causal Attributions about Disease Onset and Relapse in Patients with Systemic Vasculitis
Peter C. Grayson, Naomi A. Amudala, Carol A. McAlear, Renée L. Leduc, Denise Shereff, Rachel Richesson, Liana Fraenkel, Peter A. Merkel
The Journal of Rheumatology May 2014, 41 (5) 923-930; DOI: 10.3899/jrheum.131096
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

CAUSAL ATTRIBUTIONS
ILLNESS PERCEPTIONS
VASCULITIS

Related Articles

Cited By...

More in this TOC Section

  • The Effect of Everyday Discrimination on Systemic Lupus Erythematosus Disease Activity and Mental Health Outcomes
  • Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor–Induced Inflammatory Arthritis
  • Clinical and Epidemiological Features of Juvenile-Onset Systemic Sclerosis From a Nationwide Survey in Japan
Show more Article

Similar Articles

Keywords

  • CAUSAL ATTRIBUTIONS
  • ILLNESS PERCEPTIONS
  • vasculitis

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire